Search Results for "New Treatment For Hepatitis B"

11:57 EDT 29th April 2016 | BioPortfolio

Matching Channels

Hepatitis B

Hepatitis A

Hepatitis C

Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...

Hepatitis E virus HEV

Hepatitis B virus HBV

Matching News

Deciding on the Best Treatment in Patients With Hepatitis B

Recent recommendations and their impact on the management of patients with hepatitis B, including immune-tolerant hepatitis B, immune-active hepatitis B, and inactive chronic hepatitis, are reviewed. ...

Hepatitis C treatment made easy

A new drug combination may simplify hepatitis C treatment for both patients and physicians, suggests a new study. The once-daily sofosbuvir-velpatasvir pill aims to simplify treatment for the majority...

Screening Inmates for Hepatitis C Benefits General Community: Study

MONDAY, Nov. 23, 2015 -- A prison-based hepatitis C screening and treatment program could benefit the broader community, researchers suggest. Besides reducing the spread of hepatitis C after prisoners...

An Unforeseen Complication of the New Hepatitis C Drugs

Hepatitis B might flare during treatment for hepatitis C.

Ledipasvir/sofosbuvir Treatment in Hepatitis C Virus

What are the changes in the apolipoprotein profile of patients with hepatitis C during and after treatment with ledipasvir and sofosbuvir with and without ribavirin? Journal of Viral Hepatitis

Enhanced treatment for hepatitis C could cut prevalence by 80%

Novel antiviral therapies for hepatitis C could reduce the prevalence of the blood-borne infection by more than 80%, according to an analysis by Yale researchers. The finding raises the possibility of...

Mycophenolate mofetil effective as first-line treatment for autoimmune hepatitis

In a real-world retrospective study, researchers found mycophenolate mofetil treatment to be safe and effective for the treatment of autoimmune hepatitis in treatment-naive patients, according to publ...

Pharmalot, Pharmalittle: New $300 hepatitis C treatment in development

A nonprofit is working with an Egyptian drug maker to develop a combination hepatitis C treatment that will sell for less than $300.

Matching PubMed Articles

The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service.

Hepatitis C treatment uptake in Australia is low. To increase access to hepatitis C virus treatment for people who inject drugs, we developed a community-based, nurse-led service that linked a viral h...

The New Era of Interferon-Free Treatment of Chronic Hepatitis C.

Within the development and approval of several new direct-acting antivirals (DAA) against hepatitis C virus (HCV), a new era of hepatitis C therapy has begun. Even more treatment options are likely to...

Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus co-infected patients from Sub-Saharan Africa.

In Sub-Saharan Africa, seroclearance of hepatitis B surface antigen (HBsAg) and hepatitis B "e" antigen (HBeAg), including their quantifiable markers, have rarely been evaluated during long-term antiv...

Hepatitis C associated to substance abuse: ever closer to a treatment without Interferon.

With 3-4 million of new infections occurring annually, hepatitis C virus (HCV) infection is a global Public Health problem. In fact, hepatitis C virus infection is one of the leading causes of liver d...

Successful treatment of chronic hepatitis C with triple therapy in an opioid agonist treatment program.

People who inject drugs (PWID) constitute 10 million people globally with hepatitis C virus, including many opioid agonist treatment patients. Little data exist describing clinical outcomes for patien...

Search Whole site using Google

Quick Search
Advertisement Advertisement